Boston Public Health Commission Hosts Black Women’s Health Conference at Boston University to Address Critical Health Concerns
人生一定要有的八個朋友: 推手(Builder)、 支柱(Champion)、 同好(Collaborator)、 夥伴(Companion)、 中介(Connector)、 開心果(Energizer)、 開路者(Mind Opener)、 導師(Navigator)。 chutze@bostonorange.com ******************* All rights of articles and photos on this website are reserved.
網頁
- 大波士頓時事新聞
- ACDC 亞美社區發展協會
- 包氏文藝中心 Four Ways to Celebrate the Year of the Snake
- 波士頓亞美電影節/波士頓台灣電影節
- 波士頓華埠社區中心/華美福利會/華埠社區聯盟/ 華人醫務中心/ 亞美社區發展協會/ 華夏文化協會
- AAC TAP CACAB NAAAP AARW AAWPI ASPIRE AWH WANG YMCA QARI
- Plays - Huntington, Boston Lyric, Company One
- 音樂 - 中華表演藝術基金會
- 商會 - ACE Nextgen, 128 Cute, OCEAN, TCCNE, TCCYNE,波克萊台商會,波士頓華商會,波士頓亞裔房東會
- 創業 - Startup Boston
- 博物館 - Guggenheim
- Greentown Labs newsletter /MIT ClimateTech
- 生物醫藥 - BTBA/SAPANE/CABA
- BIOVision/ Boston MedTech / Mass Life Sciences
- Mass BIO / LaunchBIO
- 麻州州長動態 -
- 波士頓市、昆士市,摩頓市、羅爾市
- 波士頓移民進步辦公室通訊/ Office of Women's Advancement/ Community Preservation Act
- Boston City Councilor's updates
- 馬惠美 - 麻州眾議員
- 大學沙龍 第245期 李建忠-2026 ASI 奇點展望 1/4
星期一, 9月 23, 2024
Boston Public Health Commission Hosts Black Women’s Health Conference at Boston University to Address Critical Health Concerns
星期日, 9月 22, 2024
WHO endorses dual-stain cytology (CINtec PLUS) testing in its cervical cancer prevention guidelines, advancing patient care and underlining Roche’s role in pioneering cervical cancer solutions
WHO endorses dual-stain cytology (CINtec PLUS) testing in its cervical cancer prevention guidelines, advancing patient care and underlining Roche’s role in pioneering cervical cancer solutions
- Roche’s CINtec PLUS Cytology is the only FDA-approved and CE-marked dual-stain test to triage human papillomavirus (HPV)-positive cervical cancer screening test results
- Dual-stain biomarkers aid in detection of cervical precancer and may reduce the number of women who undergo unnecessary colposcopy procedures while allowing earlier intervention for those who are at higher risk of developing cervical cancer.
- This recognition follows the American Society for Colposcopy and Cervical Pathology (ASCCP)’s recent inclusion of dual-stain testing in cervical cancer screening guidelines, as well as other WHO prequalifications of Roche’s cobas HPV test
Basel, 23 September 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the World Health Organization (WHO) has included dual-stain cytology testing in its cervical cancer prevention guideline.1 The Roche CINtec® PLUS Cytology test is the only FDA-approved and CE-marked dual-stain test that helps identify human papillomavirus (HPV)-positive individuals who are most at risk of developing cervical precancer and cancer.
The WHO joins the American Society for Colposcopy and Cervical Pathology (ASCCP), which in March also updated its cervical cancer screening guidelines2 to include dual-stain as a triage test for HPV-positive individuals. If the dual-stain test is positive, the patient is at higher risk of having or developing precancer or cancer, and clinicians should recommend immediate colposcopy. However, if the dual-stain test is negative, the risk of precancer is low and individuals may follow up by retesting at a later time to determine if their body has taken care of the infection and eliminated the risk on its own. This may result in fewer women unnecessarily undergoing colposcopy procedures.
“Adding dual-stain cytology to the WHO guidelines further reinforces the value of our biomarker-based CINtec PLUS Cytology test to identify patients with an elevated risk of cervical cancer,” said Matt Sause, CEO of Roche Diagnostics. “HPV infections can cause cervical cancer, a potentially deadly disease that is highly preventable. Consequently, it is critical to determine who is most at risk.”
The CINtec PLUS Cytology test can simultaneously detect when two biomarkers (p16 and Ki-67) are present within the same cell – a strong indicator that it is undergoing transformation and may turn cancerous. By identifying those individuals who are at higher risk of developing cervical disease, CINtec PLUS Cytology helps provide labs, clinicians and patients with important information to guide patient management. This could reduce the number and frequency of follow-up visits, saving worry, time and money. The test can be performed using the same liquid sample that is used for HPV or Pap cytology testing, eliminating the need for additional or repeat sample collection.
The revised WHO guidelines represent an important step forward in achieving the organisation’s three cervical cancer elimination goals3, and a catalyst for ensuring that 90% of those identified with cervical disease receive appropriate treatment. With the recent news that the WHO has awarded prequalification designation to the cobas® HPV test on the cobas 4800, Roche’s entire portfolio of HPV tests on the 4800, 5800, 6800 and 8800 systems is now WHO prequalification-approved for both clinician-collected and self-collected samples.
About the Roche Cervical Cancer Portfolio
HPV is the known cause of more than 95% of all cervical cancers.4 Roche’s cervical cancer portfolio includes the cobas HPV test, used for primary screening and co-testing. While Pap cytology can potentially detect abnormalities in the cervix, cobas HPV detects 14 types of high-risk HPV genotypes that put patients at higher risk of developing cervical cancer. It includes results for HPV 16, HPV 18 and 12 other high-risk pooled genotypes.3
The HPV self-collection solution is approved for use with Roche's cobas HPV test. The cobas HPV test runs on the cobas 4800 and the fully automated cobas 5800/6800/8800 Systems, which offer the fastest time to results, providing up to 96 results in about three hours, and 384 results for the cobas 6800 System and 1,056 results for the cobas 8800 System in an eight hour shift. The portfolio also includes CINtec PLUS Cytology, the only FDA-approved dual-stain cytology product and CINtec Histology, the only FDA-cleared p16 biomarker technology that can help pathologists confirm the presence of pre-cancerous cervical lesions. The CINtec PLUS Cytology test can run on the BenchMark ULTRA IHC/ISH system. In countries accepting the CE mark, the CINtec PLUS Cytology test can be used to triage HPV-positive results.
The IMPACT trial, used to validate the clinical performance of the Roche cervical cancer portfolio, had representation from diverse patient segments, including 21 percent Black, 24 percent Hispanic-Latino and 0.3 percent American Indian or Alaskan Native participants.5 This diversity was critical to accurately assess the performance of the cobas HPV test and dual stain cytology in patient populations with higher incident rates of HPV. Learn more now: http://diagnostics.roche.
Roche is piloting a disease management software called navify® Cervical Screening. It aims to support health systems to increase adherence to clinical guidelines, reduce under- and over-testing and optimise healthcare resources with an organised approach to screening.
星期六, 9月 21, 2024
Methuen市長Neil Perry辭世 麻州長發文哀悼
Governor Healey and Lieutenant Governor Driscoll Issue Statement on Passing of Methuen Mayor Neil Perry
第16屆波士頓亞美電影節訂10月17日開幕 10/26 特別放映「INTERIOR CHINATOWN」
| 波士頓亞美電影節創辦人甄翠嬿(左)和副主任陳曉瑩(右) 宣佈第16屆影展訂 10月17日至27日舉行。(周菊子攝) |
| 波士頓亞美電影節志工描述影片,籲請支持者參加9月30日高爾夫球賽等活動, 謝祝影展籌款。(周菊子攝) |
該小說原作,已於2022年發行中文版,探討流行文化、移民及種族同化等議題,有書評形容該書是”對亞洲人的刻板印象的尖銳控訴,以及在這個快速變化的世界中感覺被忽視的被遺棄者的寓言”。
| 志工們在影展前派對展示相關文宣。(周菊子攝) |
波士頓亞美電影節創辦人甄翠嬿 (Susan Chiensen) 和電影節主任陳曉瑩 (Connie Chan)和電影節志工9月19日晚在包氏文藝中心 (Pao Arts Center)舉辦預告派對,向支持者匯報,今年有「我們所愛的一切 (All That We Love) 」和「未來日期 (Future Date)」這2
| 陳曉瑩表示,影展期間有許多義工從旁協助。(周菊子攝) |
| 第16屆波士頓亞美電影節要放映共13部影片。 |
另1部劇情片,以及2部紀錄片,分別為訂10月19日(週六)下午5點放映,由Stanley
Wong執導的「未來日期 (Future
Date)」,10月19日晚上8點半放映由Elixabeth
Ai執導的「新浪潮
(New Wave)」,10月20日(週日)下午1點半,由Kenji
Tsukamoto執導的「Ashima」。
| 波士頓台灣影展協會共會長林致中 (左)到場支持友會活動。(周菊子攝) |
第16屆波士頓亞美電影節已開始預售門票,開幕及閉幕場門票20元,劇情片及短片,現場15元,特別放映30元,另有套票150元,以及觀賞所有短片的套票65元。
查詢影片詳情可上網https://baaff.org/2024-schedule,以及https://mailchi.mp/aarw/baaff-live2024。
星期五, 9月 20, 2024
朗朗、波士頓市長吳弭四手聯彈 宣揚人人都可學音樂理念 (附視頻)
![]() |
| 波士頓市長吳弭和國際知名鋼琴家朗朗四手聯彈鋼琴。(周菊子攝) |
| 波士頓藝術學校代理校長Tyrone Sutton(右起),請波士頓市長吳弭 和鋼琴家朗朗和學生講話。(周菊子攝) |
| 波士頓藝術學校代理校長Tyrone Sutton(右起),訪談朗朗和波士頓市長吳弭, 請它們回答學生提問。(周菊子攝) |
十年前,朗朗把「靈感之鑰」這項目帶到麻州、波士頓。波士頓市政府表示,陸續有波士頓藝術學校
(BAA),Chittick,
Edison, Hennigan, JFK, Mattahunt, Umana,以及 Orchard Gardens等學校參加了這項目。
| 朗朗夫婦(右三、四)和波士頓市長吳弭(右五),波士頓市議員Sharon Dunkan(右二), 波士頓公校副總監陳珮(左二),朗朗國際音樂基金會執行長盧卡斯(左五)等人合影。 (周菊子攝) |
在回答提問時,朗朗表示,當年是受到電視卡通片啟發,才開始學彈鋼琴。擅拉二胡的父親在他9歲時,為他買了鋼琴,儘管那時他的手還顯小,有時要彈好一曲很有挑戰性,他卻愛上這奢侈的大玩具,真的下了很多苦工凱來練習。
| 朗朗和波士頓藝術學校學生們合影。(周菊子攝) |
一名學生趕在朗朗離開前問,朗朗花了多少時間才成名。朗朗笑說,他17歲那年 (1999),他代替身體不適的André
Watts和芝加哥交響樂團合作,演奏了柴可夫斯基第一鋼琴協奏曲,這才開啟了他的音樂人生。
| 左起,波士頓市長吳弭和朗朗,以及當天上台表演的小朋友,音樂老師,波士頓 音樂學校校長合影。(周菊子攝) |
朗朗雖然不是經常來波士頓,但2022年也曾為唐卡藝術大師娘本 (Niangben)的展覽開幕, 來到波士頓。今年為波士頓交響樂團音樂季開幕演出之後,已預定將於2025年2月28日,再來波士頓交響樂廳演出。
![]() |
| 波士頓市長吳弭特地把2個兒子都帶到現場,看媽媽和國際知名鋼琴家朗朗合奏。 (周菊子攝) |
| 波士頓藝術學校是波士頓公校中唯一以表演藝術為教學重心的 學校,新校舍三年前才啟用。(周菊子攝) |
| 波士頓藝術學校座落在紅襪隊芬衛球場對面。(周菊子攝) |
麻州經濟援助協調會批准130萬元抵稅優惠 預計帶來4480萬元私人投資
| ||
|
麻州長指派18人組成文化經濟顧問委員會
Healey-Driscoll Administration Appoints Cultural Economy Advisory Council Members
BOSTON –Today, the Healey Driscoll Administration appointed members of the Cultural Economy Advisory Council, a group comprised of public and private sector stakeholders charged with exploring policies that support artists and cultural organizations, examining ways to create economic opportunities in the arts and culture sector, and promoting cultural equity in the arts. Governor Healey established the council earlier this year to bolster Massachusetts’ creative economy, which adds $27 billion to the state economy each year and supports 135,000 jobs across the state.
"We are excited to kick off this effort to support our cultural economy, particularly as Massachusetts cultural and arts organizations host festivities celebrating the 250th anniversary of America's founding as part of our Massachusetts 250 initiative over the next two years,” said Governor Maura Healey. “Thank you to these council members who will help our administration identify ways to support artists and drive economic opportunity for this important sector."
“Massachusetts is home to iconic cultural and arts organizations, from world-famous museums and concert halls in Boston to theaters and artists cooperatives in the Berkshires,” said Lieutenant Governor Kim Driscoll. “Our administration is committed to investing in this sector, which contributes billions of dollars to our economy and supports thousands of good, rewarding jobs in every region of our state.”
“Our cultural and arts organizations are so important to the economic well-being of cities and towns across Massachusetts,” said Economic Development Secretary Yvonne Hao. "They support small businesses and arts entrepreneurs, add jobs, and make our state one of the best places to live. We’re excited to launch this council and look forward to working with partners to find ways to help this sector thrive.”
"We are fortunate to have a wealth of arts and culture organizations in Massachusetts that offer visitors and residents a place to bring their families, make new memories, and experience the best our state has to offer," said Massachusetts Office of Travel and Tourism Executive Director Kate Fox. "This council will allow us to identify ways to support the Massachusetts creative economy and advance important priorities like equity and job creation."
The council consists of representatives of the creative tourism community, performing arts sector, and state and local government and is co-chaired by Economic Development Secretary Yvonne Hao and Massachusetts Office of Travel and Tourism Executive Director Kate Fox. The Council will work in close partnership with the Massachusetts Cultural Council, the state’s arts agency charged with bolstering the creative and cultural sector and will present recommendations for cultural development and jobs growth to Governor Healey.
Cultural Policy Development Advisory Council Members:
Economic Development Secretary Yvonne Hao (Co-Chair)
Kate Fox, Executive Director, Massachusetts Office of Travel and Tourism (Co-Chair)
Michael Bobbitt, Executive Director, Massachusetts Cultural Council
Tiffancy Allecia, Executive Director, Springfield Creative City Collective
Luke Blackadar, Deputy Director, Arts & Business Council of Greater Boston
Representative Mindy Domb, House Chair, Joint Committee on Tourism, Arts and Cultural Development
Magie Gaipo-Scott, Senior Director, Government Affairs & Legal Affairs, Museum of Fine Arts Boston
Deborah Hall, Executive Director, YWCA of Central Massachusetts
Candace "Lee" Heald, AHA! New Bedford
Joyce Linehan, Assistant to the President for Special Projects, Massachusetts College of Art and Design
Senator Paul Mark, Senate Chair, Joint Committee on Tourism, Arts and Cultural Development
Ming Min Hui, Executive Director, Boston Ballet
Lynda Roscoe Hartigan, Executive Director and Chief Executive Officer, Peabody Essex Museum
Emily Ruddock, Executive Director, MassCreative
Lindsey Schmid, Director of Marketing, 1Berkshire
Annis Sengupta, Director of Arts and Culture, Metropolitan Area Planning Council
Chad Smith, President and Chief Executive Officer, Boston Symphony Orchestra
Julie Wake, Executive Director at Arts Foundation of Cape Cod

